Drug News

Added 6 hours ago Drug news

Updated results from Phase III BEACON CRC trial evaluating Braftovi + Mektovi + Erbitux for BRAFV600E-mutant colorectal cancer.- Array Biopharma

Array Biopharma announced updated safety and efficacy results, including mature overall survival (OS), from the safety lead-in of the Phase...

Added 6 hours ago Drug news

FDA approves expanded indication for Adacel in Tdap.- Sanofi Pasteur.

The FDA has approved the expanded use of Adacel (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine Adsorbed)...

Added 6 hours ago Drug news

E 2006 filed with FDA for insomnia sleep-wake disorder.- Eisai.

Eisai announced that a new drug application has been submitted to the FDA for E 2006 (lemborexant), an investigational agent...

Added 1 day ago Drug news

FDA approves Amplatzer Piccolo Occluder to treat patent ductus arteriosus. Abbott

Abbott announced the FDA approved the Amplatzer Piccolo Occluder, the world's first medical device that can be implanted in the...

Added 1 day ago Drug news

Vyndaqel filed with FDA for transthyretin amyloid cardiomyopathy.- Pfizer.

Pfizer announced that the FDA accepted for filing the company’s New Drug Applications (NDAs) for Vyndaqel (tafamidis) for the treatment...

Added 1 day ago Drug news

European Commission approves Opdivo + Yervoy ( low dose) for first line treatment of renal cell carcinoma.- BMS

Bristol-Myers Squibb Company announced that the European Commission has approved the combination of Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab)...

Added 3 days ago Drug news

EUSA Pharma acquires world rights to Sylvant to treat Castleman’s disease.

EUSA Pharma announced that it has successfully completed the acquisition of the worldwide rights to Sylvant (siltuximab) from Janssen Sciences...

Added 4 days ago Drug news

Aeglea BioTherapeutics initiates phase III PEACE study for pegzilarginase to treat Arginase 1 Deficiency.

Aeglea BioTherapeutics, Inc. announced the design of its global pivotal Phase III PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical...

Added 5 days ago Drug news

Dextenza filed with FDA for ocular inflammation post surgery.- Ocular Therapeutix.

Ocular Therapeutix announced the submission of a supplemental New Drug Application (sNDA) to the FDA for Dextenza (dexamethasone ophthalmic insert)....

Added 5 days ago Drug news

Draft NICE guidance does not recommend Aimovig in migraine.- Novartis.

In draft guidelines, the National Institute for Health and Care Excellence (NICE) has announced that it has decided that Aimovig...

Search all news articles